Home›Stock Screener›Hemant Surgical Industries›Financial Statements

Hemant Surgical Industries Financial Statements

2 Years of Data
2026 - 2025

Hemant Surgical Industries financial statements. In FYNone, Hemant Surgical Industries (HSIL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 7.6% and ROE of 13.0%. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse HSIL promoter holding to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.56% 2026 data
EBITDA Margin 12.18% 2026 data
Operating Margin 10.00% 2026 data
Return on Assets 6.57% 2026 data
Return on Equity 13.04% 2026 data

Balance Sheet Ratios

Current Ratio 48.00 2026 data
Equity Ratio 50.36% 2026 data
Asset Turnover 0.87 2026 data

HSIL Revenue, Net Profit & EBITDA — Year-on-Year Growth

HSIL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Read Hemant Surgical Industries dividend payments for the complete payout history and dividend yield track record.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+85.1%
Year-over-Year
Equity Growth
+119.0%
Year-over-Year
Operating Cash Flow Growth
-740.0%
Year-over-Year
Investing Cash Flow Growth
+90.0%
Year-over-Year
Financing Cash Flow Growth
+213.6%
Year-over-Year

HSIL Income Statement — Revenue, EBITDA & Net Profit

Hemant Surgical Industries revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 7.6%. For live price, earnings ratios and company overview, see HSIL screener.

Periods ₹ Crores
Particulars None March 2026 March 2025
Revenue 0 238 112
Expenses 0 209 98
EBITDA 0 29 14
Operating Profit Margin % 0.00% 10.00% 9.00%
Depreciation 0 2 1
Interest 0 4 2
Profit Before Tax 0 24 11
Tax 0 5 2
Net Profit 0 18 8
Earnings Per Share (₹) 0.00 15.39 7.70

HSIL Balance Sheet — Assets, Liabilities & Shareholders' Equity

HSIL total assets ₹274 Cr, total equity ₹138 Cr, total liabilities ₹ Cr (2026) — ROE 13.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025
ASSETS
Total Assets 274 148
Current Assets 192 89
Fixed Assets 53 40
Capital Work in Progress 0 12
Investments 0 0
Other Assets 221 97
LIABILITIES
Total Liabilities
Current Liabilities 4 24
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 138 63
Share Capital 13 10
Reserves & Surplus 114 53

HSIL Cash Flow Statement — Operating, Investing & Financing

Hemant Surgical Industries operating cash flow ₹-32 Cr, investing ₹-3 Cr, financing ₹69 Cr, net cash flow ₹34 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025
Operating Activities -32 5
Investing Activities -3 -30
Financing Activities 69 22
Net Cash Flow 34 -4